Service profile
Cognition Therapeutics
Biopharmaceutical company developing disease-modifying therapies for Alzheimer's disease and dementia through sigma-2 receptor complex modulation, with clinical-stage programs targeting neurodegeneration and cognitive decline.
About
What Cognition Therapeutics is
Biopharmaceutical company developing disease-modifying therapies for Alzheimer's disease and dementia through sigma-2 receptor complex modulation, with clinical-stage programs targeting neurodegeneration and cognitive decline.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://cognitiontherapeutics.com |
| Status coverage | Public status page |
| Founded | 2007 |
| Headquarters | Pittsburgh, Pennsylvania, United States |
| Categories | Enterprise, Healthcare |
Loading offerings...
Alternatives
